Cargando…

Ocular Adverse Effects in Atopic Dermatitis Patients Treated With Dupilumab: A Bibliometric Analysis

BACKGROUND: Atopic dermatitis (AD) is one of the most common chronic inflammatory skin disorders. Dupilumab, the first targeted biological drug approved for the treatment of AD, has been widely used, along with increasing ocular adverse effects (AEs). OBJECTIVE: To perform a bibliometric analysis of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jia, Qian-Nan, Qiao, Ju, Fang, Kai, Zeng, Yue-Ping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8927737/ https://www.ncbi.nlm.nih.gov/pubmed/35308529 http://dx.doi.org/10.3389/fmed.2022.802036

Ejemplares similares

Dupilumab for atopic dermatitis
Publicado: (2019)

Ocular Surface Diseases Induced by Dupilumab in Severe Atopic Dermatitis
por: Maudinet, Adrien, et al.
Publicado: (2019)

Conjunctivitis in patients with atopic dermatitis treated with dupilumab
por: Ferreira, Sandra, et al.
Publicado: (2020)

Severe atopic dermatitis and dupilumab
por: Bernardo, Wanderley, et al.
Publicado: (2023)

Is Dupilumab as Effective in Intrinsic Atopic Dermatitis as It Is in Extrinsic Atopic Dermatitis?
por: Gelato, Federica, et al.
Publicado: (2023)

Case Report: The Application of Dupilumab in Atopic Dermatitis Children Complicated With Nephrotic Syndrome
por: Yang, Ya-Qi, et al.
Publicado: (2022)

Clinical Characteristics and Treatment for Dupilumab-Related Ocular Complications in Atopic Dermatitis Patients
por: Tauqeer, Zujaja, et al.
Publicado: (2022)

Dupilumab in the Treatment of Cheilitis in Atopic Dermatitis Patients
por: Shan, Jinpeng, et al.
Publicado: (2022)

Purpuric Drug Eruption in a Patient with Atopic Dermatitis Treated with Dupilumab
por: WANG, Mingxia, et al.
Publicado: (2022)

Efficacy and Safety of Dupilumab in Chinese Patients With Atopic Dermatitis: A Real-World Study
por: Zhou, Bingjing, et al.
Publicado: (2022)

Asthma improvement in patients treated with dupilumab for severe atopic dermatitis
por: Dubini, Marco, et al.
Publicado: (2023)

Identification of Risk Factors for Dupilumab-associated Ocular Surface Disease in Patients with Atopic Dermatitis
por: ACHTEN, Roselie E., et al.
Publicado: (2022)

Case report: Dupilumab leads to an increased chance of head and neck Staphylococcus aureus infection in atopic dermatitis patients
por: Chen, Min, et al.
Publicado: (2023)

Alopecia areata after dupilumab for atopic dermatitis
por: Mitchell, Krystal, et al.
Publicado: (2018)

Onychodystrophy associated with dupilumab therapy for atopic dermatitis
por: Zubek, Amanda E., et al.
Publicado: (2020)

Practical Management of Patients with Atopic Dermatitis on Dupilumab
por: Papp, Kim A., et al.
Publicado: (2021)

Efficacy of Dupilumab in Atopic Dermatitis: The Patient’s Perspective
por: de Bruin-Weller, Marjolein, et al.
Publicado: (2021)

The Posology of Dupilumab in Pediatric Patients With Atopic Dermatitis
por: Kamal, Mohamed A., et al.
Publicado: (2021)

Improvement of atopic dermatitis and alopecia universalis with dupilumab
por: Alotaibi, Lama, et al.
Publicado: (2021)

Remission of alopecia universalis in a patient with atopic dermatitis treated with dupilumab
por: Smogorzewski, Jan, et al.
Publicado: (2019)

Immune Thrombocytopenic Purpura in a Patient with Atopic Dermatitis Treated with Dupilumab
por: FREY, Surina, et al.
Publicado: (2021)

New Onset of Alcohol Flushing in an Atopic Dermatitis Patient Treated with Dupilumab
por: Choi, Hoon, et al.
Publicado: (2023)

Recalcitrant Palmar-Plantar Atopic Dermatitis Successfully Treated with Dupilumab: A Case Series
por: Deng, Lin, et al.
Publicado: (2022)

Atopic Dermatitis with Multiple Comorbidities Treated with Dupilumab. A Case Report and Review of the Literature Regarding the Safety of Dupilumab
por: Mitroi, George G., et al.
Publicado: (2022)

Facial Redness in Atopic Dermatitis Patients Treated With Dupilumab: A Case Series
por: Seok, Seung Hui, et al.
Publicado: (2020)

Alcohol-induced facial flushing in a patient with atopic dermatitis treated with dupilumab
por: Igelman, Sean J., et al.
Publicado: (2020)

Work ability and quality of working life in atopic dermatitis patients treated with dupilumab
por: Bosma, Angela L., et al.
Publicado: (2021)

Recalcitrant erythrodermic ichthyosis with atopic dermatitis successfully treated with Dupilumab in combination with Guselkumab
por: Steinhoff, M., et al.
Publicado: (2021)

Transitory Dissemination of Molluscum Contagiosum in a Patient Treated with Dupilumab for Atopic Dermatitis
por: FERRUCCI, Silvia, et al.
Publicado: (2020)

The evaluation of dupilumab treatment response in atopic dermatitis patients
por: Askin, Ozge, et al.
Publicado: (2020)

Dupilumab for the treatment of alopecia areata in children with atopic dermatitis
por: Cho, Sung Kyung, et al.
Publicado: (2021)

High dupilumab levels in tear fluid of atopic dermatitis patients with moderate‐to‐severe ocular surface disease
por: Achten, Roselie, et al.
Publicado: (2023)

Treatment Guidelines for Atopic Dermatitis Since the Approval of Dupilumab: A Systematic Review and Quality Appraisal Using AGREE-II
por: Ghazal, Stephanie, et al.
Publicado: (2022)

Integrated metabolomics and lipidomics study of patients with atopic dermatitis in response to dupilumab
por: Zhang, Lishan, et al.
Publicado: (2022)

Clearance of Chronic Actinic Dermatitis With Dupilumab Therapy in Chinese Patients: A Case Series
por: Ali, Kamran, et al.
Publicado: (2022)

Dupilumab Provides Rapid and Sustained Improvement in SCORing Atopic Dermatitis Outcomes in Paediatric Patients with Atopic Dermatitis
por: WOLLENBERG, Andreas, et al.
Publicado: (2022)

Weight gain in patients with severe atopic dermatitis treated with dupilumab: a cohort study
por: Johansson, Emma Kristin, et al.
Publicado: (2020)

COVID-19 Symptoms Are Attenuated in Moderate-to-Severe Atopic Dermatitis Patients Treated with Dupilumab
por: Ungar, Benjamin, et al.
Publicado: (2022)

Recommendations for Vaccination in Children with Atopic Dermatitis Treated with Dupilumab: A Consensus Meeting, 2020
por: Martinez-Cabriales, Sylvia A., et al.
Publicado: (2021)

Pustular Psoriasis in a Patient Treated with Dupilumab for Atopic Dermatitis: A Case Report
por: Liu, Li, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_uqm7hkff9snf2dmr3ffcpniq96